NASDAQ · Medical - Care Facilities

biote Corp. (BTMD) Stock

$2.36 +3.51% NASDAQ: BTMD Healthcare

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization.

Valuation

MetricValue
Price$2.36
Market Cap$104.09M
P/E Ratio4.58
P/B Ratio-1.25
P/S Ratio0.53
EPS (TTM)$0.00
52-Week High$4.75
52-Week Low$1.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-22.91%
ROA17.53%
ROCE47.74%
Gross Margin20.31%
Operating Margin20.31%
Net Margin8.29%
Debt/Equity-1.93
Current Ratio1.22

Annual Financials (USD)

Metric20212022202320242025
Revenue$139.0M$165.0M$185.0M$197.0M$192.0M
Operating Profit$35.0M$-61.0M$29.0M$32.0M$36.0M
Net Profit$33.0M$-1.0M$3.0M$3.0M$27.0M
EPS$-0.87$0.16$0.13$0.09$0.74
Op Margin24.8%-36.8%15.5%16.0%18.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$54.0M$112.0M$155.0M$122.0M$108.0M
Total Liabilities$50.0M$170.0M$192.0M$225.0M$158.0M
Cash$27.0M$79.0M$89.0M$39.0M$24.0M
Borrowings$37.0M$120.0M$115.0M$111.0M$110.0M

Latest News

How The Evolving Story For biote (BTMD) May Shape Future Investor Expectations Simply Wall St. · Jun 6, 2026 Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer Business Wire · Jun 1, 2026 biote Corp. Q1 2026 Earnings Call Summary Moby · May 7, 2026 biote Q1 Earnings Call Highlights MarketBeat · May 6, 2026 Biote (BTMD) Q1 2026 Earnings Call Transcript Motley Fool · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$34.0M$-9.0M$27.0M$45.0M$35.0M
Investing Cash Flow$-8.0M$-4.0M$-5.0M$-25.0M$-12.0M
Financing Cash Flow$-4.0M$-8.0M$0$-65.0M$-41.0M
Net Cash Flow$10.0M$52.0M$10.0M$-50.0M$-15.0M
Free Cash Flow$30.0M$-11.0M$24.0M$39.0M$30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA4.75
FCF Yield28.82%
Quick Ratio0.80
Interest Coverage3.27
Return 1Y-42.77%
Return 3Y-67.60%
Return 5Y-76.80%

Ownership

Insiders Held10.39%
Institutions Held67.17%
Institutions Float Held74.96%
Institutional HolderSharesReport Date
325 Capital Llc4,548,1272026-03-31
Bandera Partners LLC2,065,4822026-03-31
Blackrock Inc.1,739,2442026-03-31
Vanguard Capital Management LLC1,113,8552026-03-31
Acadian Asset Management. LLC697,8552026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABOS $2.27 -0.66% -1.17 $163.60M 0.00%
ACTU $1.09 -5.22% -2.73 $26.08M 0.00%
ANIK $19.61 -5.43% -19.58 $262.44M 0.00%
INO $1.04 +0.97% -2.73 $55.73M 0.00%
JYNT $8.60 +2.95% 45.89 $122.55M 0.00%

About biote Corp.

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.

biote Corp. is led by CEO Bret Christensen, employs 217 people, headquartered in US, publicly traded since 2021.

biote Corp. (BTMD) stock trades at $2.36 with a market capitalization of $104.09M. The stock is valued at a price-to-earnings (P/E) ratio of 4.58, price-to-book of -1.25, price-to-sales of 0.53. Over the past 52 weeks the stock has ranged between $1.27 and $4.75, and currently trades 50.3% below its 52-week high.

On profitability, biote Corp. generates a return on equity (ROE) of -22.91%, return on capital employed of 47.74%, an operating margin of 20.31%, a net profit margin of 8.29%.

Official website: biote.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides